MET

MetLife, Inc.

Fundamental data last updated:November 19, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Financial Services

industry

Insurance - Life

Exchange

NYSE

County of HQ

United States

Next Earnings Date

02/03/2027

Business Summary

MetLife operates with a formidable business model centered around life insurance and financial services. The company generates cash through premium collections and investment income, leveraging its vast customer base. Its competitive moat is fortified by brand reputation and extensive distribution networks, ensuring customer retention. By offering a diverse range of products, MetLife locks in clients with comprehensive financial solutions.

 


VALUATION

P/E

13.20

Market Cap ($M USD)

$64.02B

Forward P/E

9.95

PEG

0.74

PRICE TO SALES

0.78

PRICE TO BOOK

2.91

EV / EBITDA

8.48

5-Year Average P/E

Free Cash Flow Yield

23.44%

DCF Value

$176.54

Graham Number

$79.74

Price to FCF

4.27

EV to FCF

4.39

Earnings Yield

7.93%

FCF Yield

23.44%

DIVIDEND

Yield

2.30%

Annual Payout

$2.35

Payout Ratio

32.42%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$8.07

Next Year EPS Growth Estimate

$10.24

Next Year Revenue Growth Estimate

$79.37B

Return on Equity (ROE)

19.46%

FREE CASH FLOW

Operating Margin

8.44%

Debt-to-Equity

0.98

Piotroski F-Score

8

Altman Z-Score

0.68

Return on Invested Capital (ROIC)

0.97%

Current Ratio

2.29

Quick Ratio

2.29

Net Debt to EBITDA

0.24

Interest Coverage

6.25

Gross Profit margin

29.23%

FCF PER SHARE

$23.63

REVENUE PER SHARE

$129.59

Gainseekers Quantitative Analysis

Summary

MetLife, Inc. appears significantly undervalued when juxtaposed with its DCF Value and Graham Number. The stock has traded below its intrinsic value, suggesting a potential mispricing by the market. With a Forward P/E of 9.95 and an Earnings Yield of 7.93%, the company presents an attractive proposition for value investors. However, the Altman Z-score of 0.68 raises red flags about financial distress, indicating potential risks. Despite this, the overall valuation metrics suggest a compelling opportunity for those willing to navigate the associated risks.

AI Exposure / Tech Reliance

In the insurance industry, MetLife is poised to leverage AI for risk assessment and customer service enhancements. The company's ability to integrate modern tech could streamline operations and improve client interactions. As a life insurance giant, adapting to tech shifts is crucial for maintaining competitive advantage.

The Bull Case

For GARP investors, MetLife offers a tantalizing mix of value and growth. The robust ROIC of 0.97% and a strong Piotroski F-Score of 8 highlight efficient capital allocation and financial health. A Free Cash Flow Yield of 23.44% underscores its ability to generate substantial cash, while a solid operating margin of 8.44% reflects pricing power. These metrics paint a picture of a company with the potential for sustainable growth and profitability.

The Bear Case

Despite its strengths, MetLife's high Price/Book ratio of 2.91 and Price/Sales ratio of 0.78 suggest it may be overvalued relative to its book and sales value. The stock's proximity to its 52-week high, just 4.76% away, indicates potential overextension. Additionally, the low Altman Z-score raises concerns about financial stability. Investors should be wary of these structural risks, which could overshadow its appealing valuation metrics.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$108.63

Institutional Ownership %

1-Year Beta

0.77

Insider Buying % (6 Mo)

Distance to 52-Week High

4.76%

Distance to 52-Week Low

33.91%

EARNINGS SURPRISE %

0.36%

50-DAY SMA

$98.67

200-DAY SMA

$86.80

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.